UBS O'Connor’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-142,418
| Closed | -$382K | – | 475 |
|
|
2024
Q1 | $382K | Sell |
142,418
-384,705
| -73% | -$1.03M | 0.01% | 345 |
|
|
2023
Q4 | $1.58M | Sell |
527,123
-104,824
| -17% | -$313K | 0.05% | 211 |
|
|
2023
Q3 | $619K | Buy |
631,947
+335,000
| +113% | +$328K | 0.01% | 365 |
|
|
2023
Q2 | $413K | Buy |
296,947
+90,688
| +44% | +$126K | 0.01% | 446 |
|
|
2023
Q1 | $328K | Buy |
+206,259
| New | +$328K | 0.01% | 478 |
|
|
2022
Q4 | – | Sell |
-77,000
| Closed | -$516K | – | 103 |
|
|
2022
Q3 | $516K | Buy |
+77,000
| New | +$516K | 0.01% | 789 |
|